Vanda Pharmaceuticals (VNDA) Tax Provisions (2010 - 2026)
Vanda Pharmaceuticals recorded quarterly Tax Provisions of $100000.0 in Q1 2026, down 99.9% quarter-over-quarter from $103.2 million in Q4 2025, and up 101.27% year-over-year from $49684.5 in Q1 2025.
Vanda Pharmaceuticals' Tax Provisions history runs 12 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- In Q1 2026, Tax Provisions rose 101.27% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at $89.8 million (up 888.44% YoY), while the FY2025 annual figure was $81.8 million, up 2134.99% from the prior year.
- Tax Provisions came in at $100000.0 for Q1 2026 at Vanda Pharmaceuticals, down from $103.2 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $103.2 million in Q4 2025 to a low of -$7.9 million in Q1 2025.
- A 5-year average of $5.1 million and a median of -$257000.0 in 2023 frame the typical range for Tax Provisions.
- On a YoY basis, Tax Provisions climbed as much as 6468.11% in 2025 and fell as far as 1474.8% in 2025.
- Vanda Pharmaceuticals' Tax Provisions stood at $2.8 million in 2022, then plunged by 73.47% to $730000.0 in 2023, then sank by 322.05% to -$1.6 million in 2024, then surged by 6468.11% to $103.2 million in 2025, then slumped by 99.9% to $100000.0 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $100000.0, $103.2 million, and -$5.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 103.23 Mn |
| Sep 30, 2025 | -5.80 Mn |
| Jun 30, 2025 | -7.70 Mn |
| Mar 31, 2025 | -7.87 Mn |
| Dec 31, 2024 | -1.62 Mn |
| Sep 30, 2024 | -900,000.00 |
| Jun 30, 2024 | -998,000.00 |
| Mar 31, 2024 | -500,000.00 |
| Dec 31, 2023 | 730,000.00 |
| Sep 30, 2023 | -257,000.00 |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 2.30 Mn |
| Dec 31, 2022 | 2.75 Mn |
| Sep 30, 2022 | 2.20 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | -1.13 Mn |
| Dec 31, 2021 | 1.53 Mn |
| Sep 30, 2021 | 2.95 Mn |
| Jun 30, 2021 | 2.95 Mn |
| Mar 31, 2021 | 1.78 Mn |
| Dec 31, 2020 | 2.72 Mn |
| Sep 30, 2020 | 2.45 Mn |
| Jun 30, 2020 | 2.40 Mn |
| Mar 31, 2020 | 755,000.00 |
| Dec 31, 2019 | 1.58 Mn |
| Sep 30, 2019 | -88.15 Mn |
| Jun 30, 2019 | 18,000.00 |
| Mar 31, 2019 | 10,000.00 |
| Dec 31, 2018 | -62,000.00 |
| Sep 30, 2018 | 100,000.00 |
| Jun 30, 2018 | 90,000.00 |
| Mar 31, 2018 | -2,000.00 |
| Dec 31, 2017 | 87,000.00 |
| Sep 30, 2017 | 23,000.00 |
| Jun 30, 2017 | 7,000.00 |
| Mar 31, 2017 | 19,000.00 |
| Dec 31, 2011 | -286,000.00 |
| Sep 30, 2011 | -113,000.00 |
| Jun 30, 2011 | -51,000.00 |
| Mar 31, 2011 | 6,000.00 |
| Dec 31, 2010 | -1.86 Mn |
| Sep 30, 2010 | -2.29 Mn |
| Jun 30, 2010 | -37,000.00 |